MaltSci 麦伴科研

Appearance

Popular Reports / Clinical Medicine

This report is written by MaltSci based on the latest literature and research findings

What are the mechanisms of hypertension? ​

Abstract ​

Hypertension, a significant global health issue affecting over 1.3 billion individuals, is a multifactorial condition that poses serious risks for cardiovascular diseases, including stroke and heart failure. This review synthesizes current research to elucidate the complex mechanisms underlying hypertension, highlighting the interplay of genetic, environmental, and physiological factors. The renin-angiotensin-aldosterone system (RAAS) is identified as a critical regulator of blood pressure, with dysregulation linked to various hypertensive states. Additionally, the sympathetic nervous system's overactivity contributes to hypertension's pathophysiology, emphasizing the role of neurogenic factors. Endothelial dysfunction, characterized by reduced nitric oxide bioavailability and increased oxidative stress, further complicates hypertension management. Genetic predispositions and gene-environment interactions significantly influence individual susceptibility to hypertension, with lifestyle factors such as dietary habits, physical activity, and psychosocial stressors playing pivotal roles. The implications for prevention and treatment are profound, as lifestyle modifications and pharmacological interventions targeting these mechanisms can effectively manage hypertension. Future research should focus on innovative therapeutic strategies and a deeper understanding of the multifactorial nature of hypertension to enhance clinical outcomes.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Pathophysiological Mechanisms of Hypertension
    • 2.1 The Renin-Angiotensin-Aldosterone System (RAAS)
    • 2.2 Role of the Sympathetic Nervous System
    • 2.3 Endothelial Dysfunction and Vascular Resistance
    • 2.4 Renal Mechanisms and Sodium Regulation
  • 3 Genetic Factors in Hypertension
    • 3.1 Genetic Predisposition and Family History
    • 3.2 Gene-Environment Interactions
  • 4 Environmental and Lifestyle Factors
    • 4.1 Dietary Influences (e.g., Sodium, Potassium)
    • 4.2 Physical Activity and Sedentary Behavior
    • 4.3 Stress and Psychosocial Factors
  • 5 Implications for Prevention and Treatment
    • 5.1 Lifestyle Modifications
    • 5.2 Pharmacological Interventions
    • 5.3 Future Directions in Hypertension Research
  • 6 Conclusion

1 Introduction ​

Hypertension, commonly referred to as high blood pressure, is a multifactorial condition that significantly impacts cardiovascular health, leading to severe complications such as stroke, heart failure, and renal failure. It is estimated that over 1.3 billion individuals worldwide are affected by hypertension, making it a leading contributor to global morbidity and mortality[1]. The intricate interplay of genetic, environmental, and physiological factors underlies the pathogenesis of this condition, necessitating a comprehensive understanding of its mechanisms to develop effective prevention and treatment strategies.

Historically, the etiology of hypertension has been a subject of extensive research, with various theories proposed over the decades. The early paradigms primarily focused on hemodynamic factors and renal mechanisms, emphasizing the kidneys' role in regulating blood pressure through fluid balance[2]. However, contemporary insights reveal that hypertension is not merely a result of isolated factors but rather a complex interplay of neurohormonal activation, vascular dysfunction, and immune system involvement[3][4]. This shift in understanding highlights the need to consider a broader range of contributors, including the renin-angiotensin-aldosterone system (RAAS), sympathetic nervous system activity, endothelial dysfunction, and renal mechanisms, alongside lifestyle factors such as diet and stress[5][6].

The significance of elucidating the mechanisms of hypertension cannot be overstated. Understanding these mechanisms is crucial for identifying individuals at risk, developing targeted therapeutic interventions, and implementing effective lifestyle modifications. For instance, the RAAS has been established as a critical regulator of blood pressure, and its dysregulation is associated with numerous hypertensive conditions[7]. Similarly, sympathetic nervous system overactivity has been implicated in the pathophysiology of hypertension, underscoring the importance of neurogenic factors[8]. Furthermore, emerging research points to the role of inflammation and immune activation in hypertension, suggesting that the immune system may interact with traditional cardiovascular control mechanisms[4][9].

This review aims to synthesize current research findings to provide a comprehensive overview of the mechanisms underlying hypertension. The content is organized as follows: Section 2 will explore the pathophysiological mechanisms of hypertension, detailing the roles of the RAAS, sympathetic nervous system, endothelial dysfunction, and renal mechanisms. Section 3 will delve into genetic factors influencing hypertension, examining genetic predispositions and gene-environment interactions. Section 4 will discuss environmental and lifestyle factors, including dietary influences, physical activity, and psychosocial stressors. In Section 5, we will outline the implications for prevention and treatment, focusing on lifestyle modifications, pharmacological interventions, and future research directions. Finally, Section 6 will summarize the key findings and their relevance to hypertension management.

By integrating insights from diverse studies, this review will not only elucidate the multifactorial nature of hypertension but also highlight the potential for innovative therapeutic strategies aimed at mitigating its impact on public health. Understanding the underlying mechanisms of hypertension is essential for advancing both clinical practice and research in this critical area of cardiovascular health.

2 Pathophysiological Mechanisms of Hypertension ​

2.1 The Renin-Angiotensin-Aldosterone System (RAAS) ​

The renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in the pathophysiology of hypertension and related cardiovascular diseases. This intricate hormonal system is essential for regulating blood pressure and maintaining fluid and electrolyte balance. Its mechanisms involve several key components and pathways that contribute to the development and progression of hypertension.

RAAS begins with the secretion of renin from the kidneys, which converts angiotensinogen, a precursor produced by the liver, into angiotensin I. This inactive peptide is then converted to angiotensin II by the action of angiotensin-converting enzyme (ACE), primarily in the lungs. Angiotensin II is the principal effector peptide of RAAS and has multiple actions that promote hypertension. It exerts potent vasoconstrictive effects, increases peripheral vascular resistance, stimulates aldosterone secretion from the adrenal glands, and enhances sympathetic nervous system activity, all of which contribute to elevated blood pressure [10].

The effects of angiotensin II are mediated through its binding to specific receptors, primarily the type 1 angiotensin receptor (AT1R). Activation of AT1R leads to increased vascular smooth muscle contraction, promoting vasoconstriction and thus raising blood pressure. Furthermore, angiotensin II stimulates the release of reactive oxygen species (ROS), which contribute to endothelial dysfunction and vascular remodeling [11].

In addition to its hemodynamic effects, angiotensin II also plays a crucial role in promoting inflammation and fibrosis within the vascular system. Chronic activation of RAAS can lead to structural changes in blood vessels, including hypertrophy and remodeling, which are characteristic of hypertensive vascular disease [12]. The involvement of aldosterone, another key component of RAAS, is also significant; it promotes sodium retention, leading to increased blood volume and further exacerbating hypertension [13].

Moreover, the dysregulation of RAAS is linked to various pathological conditions beyond hypertension. For instance, excessive RAAS activation has been implicated in cardiovascular diseases, renal damage, and metabolic disorders [14]. This underscores the multifaceted role of RAAS in health and disease, where its imbalance can lead to significant clinical consequences.

Recent advancements in understanding RAAS have highlighted alternative pathways, such as the ACE2/angiotensin (1-7)/Mas receptor axis, which exhibit protective cardiovascular effects, including vasodilation and anti-inflammatory actions [15]. These insights have opened avenues for novel therapeutic strategies targeting RAAS, beyond traditional agents like ACE inhibitors and angiotensin receptor blockers, to mitigate hypertension and its associated complications [14].

In summary, the pathophysiological mechanisms of hypertension involving the RAAS are complex and multifactorial, characterized by the interplay of vasoconstriction, fluid retention, inflammation, and vascular remodeling. Understanding these mechanisms is crucial for developing effective therapeutic interventions to manage hypertension and its related disorders.

2.2 Role of the Sympathetic Nervous System ​

The sympathetic nervous system (SNS) plays a pivotal role in the pathogenesis of hypertension through various pathophysiological mechanisms. Evidence from recent studies indicates that the SNS is a primary contributor to the development and progression of hypertension, beginning from early stages and extending into hypertension-related cardiovascular diseases. The interplay between genetic predisposition, immune responses, and sympathetic activation is crucial in understanding these mechanisms.

Several key mechanisms have been identified regarding the role of the SNS in hypertension. Firstly, the activation of the SNS is associated with adrenergic overdrive, which has been documented through advanced methodologies such as microneurography and norepinephrine spillover techniques. These studies reveal that increased sympathetic nerve traffic correlates with the severity of hypertension and is widespread across various cardiovascular regions (Grassi et al., 2010; Lohmeier, 2001). Specifically, the adrenergic overdrive contributes to sustained elevations in blood pressure and the development of target organ damage, underscoring the SNS's significant impact on cardiovascular health.

Furthermore, the central nervous system (CNS) orchestrates sympathetic outflow, integrating various peripheral inputs that influence blood pressure regulation. For instance, the brain renin-angiotensin system has been implicated in modulating sympathetic outflow, highlighting the CNS's critical role in hypertension (Hirooka, 2020). This network is influenced by factors such as nitric oxide, oxidative stress, and inflammation, which collectively interact with the sympathetic pathways to exacerbate hypertension.

The relationship between the SNS and renal function is also vital. The renal sympathetic nerves are a key link in long-term arterial pressure control. Chronic alterations in renal sympathetic activity can lead to significant changes in blood pressure regulation, with increased renal adrenergic activity contributing to sustained hypertension (Lohmeier, 2001). Conversely, interventions aimed at reducing renal sympathetic outflow, such as renal denervation, have shown promise in lowering blood pressure in resistant hypertension cases (DeLalio et al., 2020).

Additionally, the SNS's role extends to various forms of secondary hypertension, including obesity-related hypertension, where neuroadrenergic factors amplify the hypertensive state. This amplification can be influenced by prior experiences that sensitize autonomic networks, demonstrating the complexity of the SNS's involvement in hypertension (DeLalio et al., 2020).

In summary, the sympathetic nervous system is integral to the pathophysiology of hypertension, with mechanisms involving adrenergic overdrive, CNS regulation of sympathetic outflow, renal sympathetic activity, and interactions with metabolic factors. These insights underline the importance of targeting the SNS in both the understanding and treatment of hypertension. Continued research into these mechanisms may yield novel therapeutic approaches to manage hypertension effectively and mitigate its associated complications.

2.3 Endothelial Dysfunction and Vascular Resistance ​

Hypertension is a complex condition characterized by multiple pathophysiological mechanisms, among which endothelial dysfunction plays a pivotal role. The endothelium, which lines blood vessels, is crucial for maintaining vascular homeostasis by regulating vascular tone through the synthesis of various factors, including nitric oxide (NO) and prostaglandins. In hypertension, endothelial dysfunction is manifested by a shift towards a proinflammatory and prothrombotic state, resulting in vasoconstriction and impaired vascular function, which are key contributors to increased cardiovascular risk [16].

One of the primary mechanisms involved in the development of endothelial dysfunction in hypertension is the reduced bioavailability of NO. This reduction is primarily due to increased oxidative stress and inflammation, which can arise from various factors such as impaired vascular shear stress and activation of the renin-angiotensin system [17]. As a consequence, the normal counteracting mechanisms that maintain vascular homeostasis are disrupted, leading to an imbalance that favors vasoconstriction [17].

Moreover, hypertension induces structural and functional changes in endothelial cells, which can lead to increased growth and vasoconstriction of vascular smooth muscle cells. This process is particularly significant in the context of diabetes mellitus, where hypertension exacerbates endothelial dysfunction, further contributing to complications such as atherosclerosis and nephropathy [18]. The interplay between hypertension and endothelial dysfunction creates a vicious cycle that can lead to further vascular remodeling and organ damage [19].

In addition to these mechanisms, hypertension is associated with various other factors that contribute to vascular dysfunction. These include excessive salt intake, water retention, and the activation of neurohormonal systems, all of which can exacerbate endothelial dysfunction [20]. The assessment of endothelial function, arterial stiffness, and biomarkers of oxidative stress and inflammation can provide insights into the extent of vascular dysfunction in hypertensive patients, which is crucial for identifying those at risk of cardiovascular events [20].

Overall, the relationship between hypertension and endothelial dysfunction is complex and multifaceted, involving a range of biological pathways that contribute to vascular resistance and the overall pathophysiology of hypertension. Understanding these mechanisms is essential for developing effective therapeutic strategies aimed at improving vascular function and mitigating the adverse effects of hypertension on cardiovascular health [21].

2.4 Renal Mechanisms and Sodium Regulation ​

Hypertension is a complex disorder characterized by an interplay of various pathophysiological mechanisms, among which renal mechanisms and sodium regulation play a pivotal role. The kidney is central to the regulation of blood pressure through its ability to manage sodium excretion, which is influenced by several factors, including pressure natriuresis, renal sodium transporters, and the renin-angiotensin-aldosterone system (RAAS).

The pathophysiology of hypertension involves the integration of multiple organ systems, with the kidney's role being critical. The kidney governs sodium excretion through mechanisms such as pressure natriuresis, where increased blood pressure leads to enhanced sodium excretion, thereby helping to regulate blood volume and pressure over the long term. This relationship is essential, as the failure of the pressure-natriuresis mechanism can lead to hypertension. When renal function is compromised, either through genetic predisposition or environmental factors such as high dietary sodium intake, the ability of the kidney to excrete sodium effectively diminishes, resulting in sodium retention and increased blood pressure[22][23].

In individuals with salt sensitivity, changes in sodium intake can lead to significant fluctuations in blood pressure. The renal handling of sodium is influenced by several factors, including genetic predispositions, dietary habits, sympathetic nervous system activity, and oxidative stress mechanisms. For instance, increased sympathetic tone is often observed in hypertensive patients and has been shown to disrupt the pressure-natriuresis relationship, thereby exacerbating hypertension[24][25].

The renal vasculature's response to angiotensin II and sympathetic nervous system activation is crucial in the pathogenesis of hypertension. Increased renal vascular resistance, often due to enhanced renal vascular tone, can lead to decreased renal blood flow and increased filtration fraction, which perpetuates hypertension[26]. Moreover, studies indicate that renal hemodynamics, particularly the regulation of renal blood flow, are fundamental in the development and maintenance of hypertension[26].

Moreover, the role of sodium in the pathogenesis of hypertension cannot be overstated. Excess sodium intake is associated with elevated blood pressure due to mechanisms such as altered electrolyte transport across cell membranes, which increases vascular resistance and contributes to the hypertensive state[27]. The accumulation of sodium can lead to endothelial dysfunction, characterized by impaired nitric oxide production, which is vital for vascular health[25].

In conclusion, the renal mechanisms involved in hypertension are multifaceted, encompassing the regulation of sodium excretion, the influence of the sympathetic nervous system, and the interplay of genetic and environmental factors. Understanding these mechanisms provides insights into potential therapeutic targets for managing hypertension and underscores the importance of dietary sodium management in hypertensive patients.

3 Genetic Factors in Hypertension ​

3.1 Genetic Predisposition and Family History ​

Hypertension is a multifactorial disorder characterized by complex interactions between genetic and environmental factors. Genetic predisposition plays a significant role in the development of hypertension, with evidence suggesting that heritability accounts for approximately 30-65% of the variance in blood pressure among individuals. High blood pressure is notably more prevalent among individuals with a strong family history, particularly before the age of 55, where it occurs 3.8 times more often in those with such a history [28].

Research indicates that genetic factors contribute substantially to the variability in blood pressure within populations. In twin studies, heritability estimates for sitting diastolic blood pressure range from 25% to 65%, while biochemical traits associated with hypertension exhibit even higher heritability, between 78-84% [28]. This suggests that genetic influences are a major determinant of blood pressure regulation.

Moreover, the genetic architecture of hypertension includes both monogenic and polygenic forms. Genome-wide association studies (GWAS) have identified numerous loci associated with hypertension, although many of these genetic variants do not affect protein-coding sequences, complicating the identification of specific causative genes [29]. Despite the challenges in pinpointing exact genetic causes, the identification of familial dyslipidemic hypertension, which occurs in about 12% of hypertension cases, highlights the importance of recognizing genetic predisposition in clinical settings. This condition is associated with increased risk for early coronary heart disease and is characterized by features such as hyperinsulinemia and central obesity [28].

The interplay between genetic factors and environmental influences further complicates the understanding of hypertension. Environmental factors, including diet, physical activity, and psychosocial stressors, interact with genetic predispositions, potentially modifying the risk of developing hypertension [30]. The identification of gene-environment interactions remains an area of active research, as it may elucidate the mechanisms through which genetic factors contribute to hypertension risk [31].

In summary, the mechanisms of hypertension are deeply rooted in genetic predisposition, as evidenced by familial patterns of the disease, heritability estimates, and the identification of specific genetic loci associated with blood pressure regulation. Understanding these genetic factors is crucial for developing targeted prevention and treatment strategies for hypertension.

3.2 Gene-Environment Interactions ​

Hypertension is a complex disorder influenced by a myriad of genetic and environmental factors, with significant interactions between the two. The genetic component accounts for approximately 30-50% of blood pressure variation, while environmental factors, including lifestyle choices and socioeconomic status, play a crucial role in the development and progression of the disease.

Genetic studies have identified numerous genetic variants associated with hypertension, although the relationship is often complicated by the context-dependent nature of these genes. For instance, gene-environment interactions suggest that the effects of genetic predispositions can be modified by environmental exposures. This is particularly evident in how individuals respond differently to environmental stressors, diet, and physical activity based on their genetic makeup [32].

Recent research highlights the significance of incorporating gene-environment interaction models to better understand hypertension. Such models consider how genetic susceptibility to hypertension can be influenced by environmental factors like stress, diet, and physical activity. For example, stress-induced hypertension may arise from repeated exposure to stressors in individuals with a genetic predisposition, where specific genes involved in cardiovascular and renal responses are activated, leading to elevated blood pressure [33].

Moreover, environmental factors such as high salt intake, obesity, alcohol consumption, and low physical activity have been linked to increased hypertension risk. The interaction of these environmental factors with genetic predispositions complicates the identification of specific genetic contributors to hypertension [34]. It has been observed that chronic stress, for instance, can exacerbate hypertension, especially in individuals who may already be genetically susceptible [35].

Research indicates that the genetic architecture of hypertension includes numerous single nucleotide polymorphisms (SNPs) that interact with environmental factors, complicating the understanding of their causal roles. The integration of omics technologies, such as metabolomics and microbiomics, is being explored to further elucidate these complex interactions and their implications for hypertension [36].

In summary, the mechanisms of hypertension are multifaceted, involving intricate interactions between genetic predispositions and environmental influences. The recognition of these gene-environment interactions is crucial for developing targeted prevention and treatment strategies for hypertension, emphasizing the need for a comprehensive approach that considers both genetic and lifestyle factors in managing this prevalent cardiovascular condition [37].

4 Environmental and Lifestyle Factors ​

4.1 Dietary Influences (e.g., Sodium, Potassium) ​

Hypertension is a multifactorial condition influenced by a complex interplay of genetic and environmental factors, with dietary influences playing a significant role. Among the various dietary components, sodium and potassium intake are particularly notable for their effects on blood pressure regulation.

Excessive sodium intake is widely recognized as a key contributor to the development of hypertension. It induces arterial hypertension through mechanisms that increase cardiac output and affect vascular reactivity and contractility. Studies have demonstrated that high sodium consumption leads to increased blood pressure levels, and conversely, restricting sodium intake can result in a reduction in blood pressure [38]. This relationship is underscored by the observation that populations with high sodium diets often exhibit higher prevalence rates of hypertension [39].

In addition to sodium, potassium intake is also crucial in managing blood pressure. Although the consensus on the role of potassium in hypertension prevention and control is not fully established, several studies suggest that higher potassium intake may have a protective effect against hypertension [40]. The balance between sodium and potassium is vital; potassium acts to counteract some of the hypertensive effects of sodium, thereby promoting vascular health and potentially lowering blood pressure [41].

Furthermore, dietary patterns, such as the DASH (Dietary Approaches to Stop Hypertension) diet, emphasize the importance of low sodium and high potassium intake alongside other beneficial dietary components, including fruits, vegetables, and whole grains. These dietary modifications have been shown to lower blood pressure effectively and prevent the onset of hypertension [41].

Environmental factors also play a significant role in dietary influences on hypertension. For instance, socioeconomic status and cultural practices can affect dietary choices, leading to variations in sodium and potassium consumption across different populations [42]. Additionally, lifestyle factors such as physical inactivity and excessive alcohol consumption further exacerbate the risk of developing hypertension [34].

In summary, the mechanisms of hypertension related to dietary influences primarily revolve around the effects of sodium and potassium intake. High sodium consumption is linked to increased blood pressure, while adequate potassium intake may help mitigate these effects. The interplay between dietary habits, environmental factors, and lifestyle choices underscores the complexity of hypertension's pathogenesis and highlights the importance of dietary management in its prevention and treatment.

4.2 Physical Activity and Sedentary Behavior ​

Hypertension is a multifactorial condition influenced by a complex interplay of environmental and lifestyle factors, particularly physical activity and sedentary behavior. The pathogenesis of hypertension involves various mechanisms that are significantly modulated by these factors.

Regular physical activity has been shown to have a beneficial effect on blood pressure regulation. Engaging in aerobic exercise can lead to reductions in blood pressure levels, highlighting its role as a modifiable lifestyle factor in hypertension management [38]. Conversely, a sedentary lifestyle has been extensively documented to negatively impact blood pressure. Sedentary behavior contributes to the development of obesity, which is a primary predictive factor for hypertension, particularly during childhood and adolescence [38].

The relationship between physical activity and hypertension can be partially explained through the sympathetic nervous system. Overactivity of the sympathetic nervous system is known to play a crucial role in the early stages of hypertension. Various lifestyle factors, including physical inactivity, can exacerbate this sympathetic overactivity, leading to elevated blood pressure [35]. Furthermore, chronic stress and sedentary behavior are associated with increased blood pressure levels, as they can provoke sympathetic nervous system responses [35].

Additionally, obesity resulting from physical inactivity can induce hyperinsulinaemia, which may further stimulate sympathetic nervous system activity, thereby increasing blood pressure [38]. This interrelationship underscores the importance of maintaining an active lifestyle to mitigate the risk of hypertension.

Moreover, the concept of gene-environment interactions is relevant in understanding hypertension. Genetic predispositions may interact with environmental factors, including physical activity levels, to influence an individual's risk of developing hypertension [32]. Therefore, individuals with a genetic susceptibility to hypertension may experience more pronounced effects from sedentary lifestyles or inadequate physical activity.

In summary, the mechanisms of hypertension related to physical activity and sedentary behavior involve a complex interaction of physiological responses, including sympathetic nervous system activity, obesity, and metabolic changes. Promoting regular physical activity and reducing sedentary behavior are critical strategies in the prevention and management of hypertension, emphasizing the need for public health interventions targeting lifestyle modifications to improve cardiovascular health outcomes [35][38].

4.3 Stress and Psychosocial Factors ​

Hypertension is a multifactorial condition influenced by various environmental and lifestyle factors, with psychosocial stress emerging as a significant contributor to its pathogenesis. The mechanisms through which stress and psychosocial factors influence hypertension can be understood through several interrelated pathways.

Firstly, chronic psychosocial stress has been hypothesized as a risk factor for hypertension. Research indicates that occupational stress, aspects of the social environment, and low socioeconomic status can significantly contribute to elevated blood pressure levels. Studies have shown that individuals exposed to chronic stress often exhibit increased cardiovascular reactivity, which is a response characterized by heightened heart rate and blood pressure during stressful situations. Furthermore, delayed recovery to baseline blood pressure levels after stress exposure is increasingly recognized as a potential mechanism linking stress to hypertension [43].

The interaction between stress and lifestyle behaviors is another critical aspect. Lifestyle-related factors such as obesity, alcohol consumption, dietary sodium intake, and physical inactivity are well-established determinants of high blood pressure [44]. Stress may exacerbate these lifestyle factors; for instance, individuals under significant stress may resort to unhealthy coping mechanisms, such as poor dietary choices or increased alcohol consumption, which can further elevate blood pressure. This interaction suggests that coping mechanisms may mediate the relationship between psychosocial stress and hypertension [44].

Moreover, the sympathetic nervous system plays a pivotal role in the development of hypertension. Stress is known to activate the sympathetic nervous system, leading to increased heart rate and vascular resistance, which can contribute to elevated blood pressure. Overactivity of this system, particularly in the early stages of hypertension, has been shown to correlate with lifestyle factors such as stress [35].

Additionally, psychosocial factors such as job strain—a combination of high work demands and low control—have been associated with higher blood pressure levels. Research has demonstrated that job strain correlates with increased ambulatory blood pressure, particularly in men, indicating that occupational stressors can have direct physiological effects on blood pressure regulation [35].

Environmental factors also play a role in this complex interplay. Studies indicate that environmental stressors, including noise and pollution, may exacerbate the effects of psychosocial stress on blood pressure [45]. The integration of these environmental determinants with psychosocial factors highlights the multifaceted nature of hypertension and underscores the importance of considering both individual and societal levels in hypertension management and prevention strategies.

In summary, the mechanisms linking stress and psychosocial factors to hypertension are multifactorial and include increased cardiovascular reactivity, lifestyle changes influenced by coping mechanisms, activation of the sympathetic nervous system, and the impact of environmental stressors. Addressing these factors through behavioral interventions and public health strategies could be pivotal in managing and preventing hypertension effectively [43][44][45].

5 Implications for Prevention and Treatment ​

5.1 Lifestyle Modifications ​

Hypertension is a multifactorial condition influenced by a variety of genetic and environmental factors. The pathogenesis of arterial hypertension is increasingly understood to involve a complex interplay of these factors, with lifestyle choices playing a significant role.

One of the primary mechanisms contributing to hypertension is obesity, particularly during childhood and adolescence, which is a predictive factor for the development of high blood pressure. The underlying mechanism is thought to be hyperinsulinaemia, which leads to hyperactivity of the sympathetic nervous system. This hyperactivity can increase vascular resistance and cardiac output, thereby elevating blood pressure levels[38].

Excessive sodium intake is another critical factor in the development of hypertension. High sodium levels can induce hypertension by increasing blood volume and enhancing vascular reactivity, which leads to elevated blood pressure. Conversely, sodium restriction has been shown to reduce blood pressure levels effectively[38].

Alcohol consumption is also linked to hypertension; excessive intake has been identified as a significant risk factor for developing high blood pressure. While the exact mechanisms remain unclear, studies suggest that reducing alcohol consumption can lead to significant decreases in blood pressure[38].

Physical inactivity is a well-documented contributor to hypertension. Regular physical exercise, particularly aerobic activities, has been shown to lower both systolic and diastolic blood pressure. Increased physical activity can improve vascular health by enhancing endothelial function and reducing sympathetic nervous system activity[38].

Moreover, lifestyle factors such as smoking have both short- and long-term effects on blood pressure. Components of tobacco smoke can increase blood pressure, highlighting the importance of smoking cessation in managing hypertension[38].

The implications for prevention and treatment of hypertension are substantial. Evidence suggests that lifestyle modifications can effectively prevent and manage hypertension. Key lifestyle interventions include:

  1. Weight Management: Maintaining a healthy body weight is crucial, as overweight individuals have a significantly increased risk of developing hypertension. Weight loss has been shown to reduce both systolic and diastolic blood pressure in hypertensive patients[40].

  2. Dietary Modifications: A diet low in sodium and rich in potassium, calcium, and magnesium is recommended. While potassium supplementation has not consistently shown a clinically significant effect, reducing sodium intake has proven effective[40].

  3. Regular Physical Activity: Engaging in regular exercise not only aids in weight management but also directly lowers blood pressure. Aerobic exercises, in particular, have been validated as effective in reducing hypertension[46].

  4. Alcohol Moderation: Limiting alcohol intake can lead to substantial reductions in blood pressure levels[40].

  5. Stress Management: Techniques such as relaxation therapies, biofeedback, and device-guided breathing may help in managing hypertension by mitigating stress-induced increases in blood pressure[47].

In summary, the mechanisms underlying hypertension involve a combination of genetic predisposition and modifiable lifestyle factors, including obesity, sodium intake, alcohol consumption, physical inactivity, and smoking. Addressing these factors through targeted lifestyle modifications is essential for both the prevention and management of hypertension, thereby reducing the associated risks of cardiovascular disease and mortality. The promotion of such lifestyle changes should be an integral part of hypertension management strategies[40][46][47].

5.2 Pharmacological Interventions ​

Hypertension is a multifaceted condition characterized by elevated blood pressure, and its pathophysiology involves a complex interplay of various mechanisms. Understanding these mechanisms is crucial for the development of effective prevention and treatment strategies, particularly pharmacological interventions.

One of the primary mechanisms contributing to hypertension is the dysregulation of the renin-angiotensin-aldosterone system (RAAS), which plays a critical role in blood pressure regulation. Activation of this system leads to increased vasoconstriction and sodium retention, resulting in elevated blood pressure. Inhibiting components of this system, such as through the use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists, has been shown to effectively lower blood pressure and reduce the risk of cardiovascular events [48].

Another significant mechanism involves endothelial dysfunction, characterized by an imbalance in the production of vasodilators and vasoconstrictors by the endothelial cells lining blood vessels. This dysfunction can lead to increased vascular resistance and contribute to hypertension. Antihypertensive therapies that improve endothelial function may offer additional benefits beyond mere blood pressure reduction [21].

Additionally, the role of immune mechanisms in hypertension has gained increasing attention. Immune cells, particularly those involved in inflammation, have been identified as key players in the development and progression of hypertension. These immune responses can lead to vascular remodeling and dysfunction, contributing to sustained high blood pressure [49]. Furthermore, interactions between the nervous system and immune system, particularly through autonomic regulation, have been shown to influence blood pressure levels [50].

Recent research has also highlighted the involvement of microRNAs in hypertension, which can modulate gene expression related to vascular function and inflammation. This epigenetic regulation may offer new therapeutic targets for hypertension management [51].

Pharmacological interventions for hypertension include a variety of drug classes, such as diuretics, beta-blockers, calcium channel blockers, and newer agents targeting different pathways. For instance, SGLT2 inhibitors and endothelin receptor blockers have emerged as promising options, particularly in patients with resistant hypertension [6]. Despite the availability of numerous antihypertensive medications, a significant proportion of patients still do not achieve optimal blood pressure control, indicating the need for continued research into novel therapeutic strategies [52].

In conclusion, the mechanisms underlying hypertension are complex and involve interactions between neurohormonal, endothelial, immune, and genetic factors. Effective prevention and treatment strategies must consider this multifactorial nature, with pharmacological interventions tailored to address the specific mechanisms contributing to each patient's condition. Continued exploration of novel therapeutic targets and approaches will be essential in improving hypertension management and reducing associated cardiovascular risks.

5.3 Future Directions in Hypertension Research ​

Hypertension is a multifactorial disease characterized by elevated blood pressure, which affects over 1.2 billion individuals globally and poses a significant risk for cardiovascular morbidity and mortality. The underlying mechanisms of hypertension are complex and involve a variety of factors including genetic predisposition, environmental influences, and various pathophysiological processes.

Recent findings have highlighted several key mechanisms contributing to the pathogenesis of hypertension. These include:

  1. Neurohormonal Activation: The renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in blood pressure regulation. Dysregulation of this system can lead to increased vascular resistance and fluid retention, both of which contribute to hypertension [53]. Additionally, heightened sympathetic nervous system activity has been identified in many hypertensive patients, which further exacerbates blood pressure elevation [8].

  2. Vascular Dysfunction: The integrity of vascular function is crucial for maintaining normal blood pressure. Changes in vascular elasticity, reactivity, and endothelial function are significant indicators of hypertension. Alterations in signaling pathways within endothelial cells and vascular smooth muscle cells, such as calcium signaling and nitric oxide pathways, are implicated in the development of hypertension [53].

  3. Immune System Involvement: Emerging evidence suggests that immune mechanisms play a critical role in hypertension. Activation of immune cells, such as macrophages and lymphocytes, can lead to chronic inflammation and tissue damage, which contribute to the progression of hypertension [49]. Furthermore, the interaction between the central nervous system and the immune system, particularly through autonomic regulation, is increasingly recognized as a key factor in blood pressure control [4].

  4. MicroRNAs: These small noncoding RNAs have been identified as regulators of gene expression involved in various biological processes, including those that contribute to hypertension. MicroRNA deregulation may lead to altered cellular functions that promote hypertension [54].

  5. Metabolic Syndrome: Hypertension is closely associated with metabolic syndrome, characterized by obesity, insulin resistance, and systemic inflammation. These factors not only increase cardiovascular risk but also complicate the management of hypertension [55].

The implications for prevention and treatment of hypertension are significant. Understanding these mechanisms opens avenues for targeted therapeutic strategies. Current treatments primarily focus on RAAS inhibition, but there is a growing interest in therapies that also address immune dysregulation and vascular function. For instance, anti-inflammatory therapies and lifestyle modifications aimed at reducing metabolic syndrome components may enhance blood pressure control [56].

Future directions in hypertension research should include:

  • Exploration of Novel Therapeutics: Investigating immune modulators and novel signaling pathway inhibitors could lead to innovative treatment approaches that go beyond traditional antihypertensive medications [56].

  • Translational Research: Further studies are needed to translate findings from basic science into clinical practice, particularly in understanding how early-life exposures and stressors may sensitize individuals to hypertension [8].

  • Longitudinal Studies: Long-term studies examining the interplay between genetic, environmental, and lifestyle factors in hypertension development will be crucial for identifying at-risk populations and developing preventive strategies [57].

In summary, hypertension arises from a complex interplay of neurohormonal, vascular, immune, and metabolic factors. Addressing these mechanisms through innovative research and targeted therapies may significantly improve hypertension management and reduce its associated health risks.

6 Conclusion ​

The mechanisms underlying hypertension are multifaceted and encompass a variety of pathophysiological processes, including neurohormonal activation, vascular dysfunction, and immune system involvement. The renin-angiotensin-aldosterone system (RAAS) remains a central focus in understanding hypertension, given its role in regulating blood pressure through fluid retention and vasoconstriction. Additionally, the sympathetic nervous system contributes significantly to the development of hypertension through adrenergic overactivity and interactions with renal mechanisms. Endothelial dysfunction and impaired vascular reactivity further exacerbate the condition, creating a vicious cycle that can lead to cardiovascular complications. Genetic predisposition and environmental factors, such as dietary influences and lifestyle choices, also play critical roles in hypertension's etiology. Future research directions should prioritize the exploration of novel therapeutic targets that address these diverse mechanisms, particularly focusing on immune modulation and the integration of lifestyle interventions. By understanding the intricate interplay of these factors, we can develop more effective prevention and treatment strategies for hypertension, ultimately reducing its burden on public health.

References ​

  • [1] William Thomas Phillips;Joyce Gensberg Schwartz. Nasal turbinate lymphatic obstruction: a proposed new paradigm in the etiology of essential hypertension.. Frontiers in medicine(IF=3.0). 2024. PMID:39219790. DOI: 10.3389/fmed.2024.1380632.
  • [2] Richard J Johnson;Dan I Feig;Takahiko Nakagawa;L Gabriela Sanchez-Lozada;Bernardo Rodriguez-Iturbe. Pathogenesis of essential hypertension: historical paradigms and modern insights.. Journal of hypertension(IF=4.1). 2008. PMID:18300843. DOI: 10.1097/HJH.0b013e3282f29876.
  • [3] Marialuisa Perrotta;Daniela Carnevale. Brain Areas Involved in Modulating the Immune Response Participating in Hypertension and Its Target Organ Damage.. Antioxidants & redox signaling(IF=6.1). 2021. PMID:34269604. DOI: 10.1089/ars.2021.0142.
  • [4] Sara Perrotta;Daniela Carnevale. Brain-Splenic Immune System Interactions in Hypertension: Cellular and Molecular Mechanisms.. Arteriosclerosis, thrombosis, and vascular biology(IF=7.4). 2024. PMID:37942610. DOI: 10.1161/ATVBAHA.123.318230.
  • [5] J E Krieger;V J Dzau. Molecular biology of hypertension.. Hypertension (Dallas, Tex. : 1979)(IF=8.2). 1991. PMID:1832415. DOI: 10.1161/01.hyp.18.3_suppl.i3.
  • [6] Sahar H Koubar;Alejandro Garcia-Rivera;Muner M B Mohamed;John E Hall;Michael E Hall;Mohamed Hassanein. Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases.. Current hypertension reports(IF=5.1). 2024. PMID:37982994. DOI: 10.1007/s11906-023-01287-9.
  • [7] Eriko Takimoto-Ohnishi;Kazuo Murakami. Renin-angiotensin system research: from molecules to the whole body.. The journal of physiological sciences : JPS(IF=3.2). 2019. PMID:31028527. DOI: 10.1007/s12576-019-00679-4.
  • [8] Baojian Xue;Alan Kim Johnson. Sensitization of Hypertension: The Impact of Earlier Life Challenges: Excellence Award for Hypertension Research 2021.. Hypertension (Dallas, Tex. : 1979)(IF=8.2). 2023. PMID:36069195. DOI: 10.1161/HYPERTENSIONAHA.122.18550.
  • [9] Vinicia Campana Biancardi;Gisele Facholi Bomfim;Wagner Luis Reis;Sarah Al-Gassimi;Kenia Pedrosa Nunes. The interplay between Angiotensin II, TLR4 and hypertension.. Pharmacological research(IF=10.5). 2017. PMID:28330785. DOI: 10.1016/j.phrs.2017.03.017.
  • [10] Ulvi Bayraktutan. Angiotensin II and Cardiovascular Disease: Balancing Pathogenic and Protective Pathways.. Current issues in molecular biology(IF=3.0). 2025. PMID:40728970. DOI: 10.3390/cimb47070501.
  • [11] Daniel A Duprez. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.. Journal of hypertension(IF=4.1). 2006. PMID:16685192. DOI: 10.1097/01.hjh.0000226182.60321.69.
  • [12] Ravi Nistala;Yongzhong Wei;James R Sowers;Adam Whaley-Connell. Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease.. Translational research : the journal of laboratory and clinical medicine(IF=5.9). 2009. PMID:19218092. DOI: 10.1016/j.trsl.2008.12.008.
  • [13] Seema Patel;Abdur Rauf;Haroon Khan;Tareq Abu-Izneid. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie(IF=7.5). 2017. PMID:28772209. DOI: 10.1016/j.biopha.2017.07.091.
  • [14] Yaqing Ruan;Yongxin Yu;Meiqin Wu;Yulang Jiang;Yuliang Qiu;Shiwei Ruan. The renin-angiotensin-aldosterone system: An old tree sprouts new shoots.. Cellular signalling(IF=3.7). 2024. PMID:39306263. DOI: 10.1016/j.cellsig.2024.111426.
  • [15] Adrian Martyniak;Przemysław J Tomasik. A New Perspective on the Renin-Angiotensin System.. Diagnostics (Basel, Switzerland)(IF=3.3). 2022. PMID:36611307. DOI: 10.3390/diagnostics13010016.
  • [16] Giovanna Gallo;Massimo Volpe;Carmine Savoia. Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications.. Frontiers in medicine(IF=3.0). 2021. PMID:35127755. DOI: 10.3389/fmed.2021.798958.
  • [17] Timothy Watson;Patrick K Y Goon;Gregory Y H Lip. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension.. Antioxidants & redox signaling(IF=6.1). 2008. PMID:18315493. DOI: 10.1089/ars.2007.1998.
  • [18] W A Hsueh;P W Anderson. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus.. Hypertension (Dallas, Tex. : 1979)(IF=8.2). 1992. PMID:1639468. DOI: 10.1161/01.hyp.20.2.253.
  • [19] Irakli Kopaliani;Basant Elsaid;Stephan Speier;Andreas Deussen. Immune and Metabolic Mechanisms of Endothelial Dysfunction.. International journal of molecular sciences(IF=4.9). 2024. PMID:39769104. DOI: 10.3390/ijms252413337.
  • [20] Vasiliki Tsigkou;Evangelos Oikonomou;Panagiotis Theofilis;Konstantinos Zisimos;Aikaterini Tsatsaragkou;Georgios Marinos;Panteleimon Pantelidis;Ourania Katsarou;Manolis Vavuranakis;Gerasimos Siasos;Dimitris Tousoulis. Markers of Vascular Dysfunction in Hypertension.. Current medicinal chemistry(IF=3.5). 2024. PMID:39069710. DOI: 10.2174/0109298673311734240718064511.
  • [21] Kodlipet Dharmashankar;Michael E Widlansky. Vascular endothelial function and hypertension: insights and directions.. Current hypertension reports(IF=5.1). 2010. PMID:20857237. DOI: 10.1007/s11906-010-0150-2.
  • [22] Alissa A Frame;Richard D Wainford. Renal sodium handling and sodium sensitivity.. Kidney research and clinical practice(IF=3.8). 2017. PMID:28680820. DOI: 10.23876/j.krcp.2017.36.2.117.
  • [23] Yoko Suzumoto;Laura Zucaro;Anna Iervolino;Giovambattista Capasso. Kidney and blood pressure regulation-latest evidence for molecular mechanisms.. Clinical kidney journal(IF=4.6). 2023. PMID:37261007. DOI: 10.1093/ckj/sfad015.
  • [24] Noelia Díaz-Morales;Eva M Baranda-Alonso;Carlos Martínez-Salgado;Francisco J López-Hernández. Renal sympathetic activity: A key modulator of pressure natriuresis in hypertension.. Biochemical pharmacology(IF=5.6). 2023. PMID:36535529. DOI: 10.1016/j.bcp.2022.115386.
  • [25] Gheun-Ho Kim. Primary Role of the Kidney in Pathogenesis of Hypertension.. Life (Basel, Switzerland)(IF=3.4). 2024. PMID:38255734. DOI: 10.3390/life14010119.
  • [26] L M Ruilope;V Lahera;J L Rodicio;J Carlos Romero. Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans?. Hypertension (Dallas, Tex. : 1979)(IF=8.2). 1994. PMID:8282328. DOI: 10.1161/01.hyp.23.1.3.
  • [27] E Reisin. Sodium and obesity in the pathogenesis of hypertension.. American journal of hypertension(IF=3.1). 1990. PMID:2155002. DOI: 10.1093/ajh/3.2.164.
  • [28] R R Williams;S C Hunt;S J Hasstedt;P N Hopkins;L L Wu;T D Berry;B M Stults;G K Barlow;M C Schumacher;R P Lifton. Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure?. Hypertension (Dallas, Tex. : 1979)(IF=8.2). 1991. PMID:1889856. DOI: 10.1161/01.hyp.18.3_suppl.i29.
  • [29] Arya Mani. Update in genetic and epigenetic causes of hypertension.. Cellular and molecular life sciences : CMLS(IF=6.2). 2024. PMID:38691164. DOI: 10.1007/s00018-024-05220-4.
  • [30] Steven C Hunt. Genetic architecture of complex traits predisposing to nephropathy: hypertension.. Seminars in nephrology(IF=3.5). 2010. PMID:20347644. DOI: 10.1016/j.semnephrol.2010.01.006.
  • [31] P W Franks. Identifying genes for primary hypertension: methodological limitations and gene-environment interactions.. Journal of human hypertension(IF=3.4). 2009. PMID:19005475. DOI: 10.1038/jhh.2008.134.
  • [32] Z Pausova;J Tremblay;P Hamet. Gene-environment interactions in hypertension.. Current hypertension reports(IF=5.1). 1999. PMID:10981041. DOI: 10.1007/s11906-999-0072-z.
  • [33] Ikhide G Imumorin;Yanbin Dong;Haidong Zhu;Joseph C Poole;Gregory A Harshfield;Frank A Treiber;Harold Snieder. A gene-environment interaction model of stress-induced hypertension.. Cardiovascular toxicology(IF=3.7). 2005. PMID:16046788. DOI: 10.1385/ct:5:2:109.
  • [34] M Kornitzer;M Dramaix;G De Backer. Epidemiology of risk factors for hypertension: implications for prevention and therapy.. Drugs(IF=14.4). 1999. PMID:10353295. DOI: 10.2165/00003495-199957050-00003.
  • [35] T G Pickering. The effects of environmental and lifestyle factors on blood pressure and the intermediary role of the sympathetic nervous system.. Journal of human hypertension(IF=3.4). 1997. PMID:9321735. DOI: .
  • [36] Panayiotis Louca;Cristina Menni;Sandosh Padmanabhan. Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.. American journal of hypertension(IF=3.1). 2020. PMID:32060494. DOI: 10.1093/ajh/hpaa022.
  • [37] Anupam Agarwal;Gordon H Williams;Naomi D L Fisher. Genetics of human hypertension.. Trends in endocrinology and metabolism: TEM(IF=12.6). 2005. PMID:15808811. DOI: 10.1016/j.tem.2005.02.009.
  • [38] H Pardell;P Armario;R Hernández. [Pathogenesis and epidemiology of arterial hypertension].. Drugs(IF=14.4). 1998. PMID:9813737. DOI: 10.2165/00003495-199856002-00001.
  • [39] J M Geleijnse;D E Grobbee;F J Kok. Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations.. Journal of human hypertension(IF=3.4). 2005. PMID:16302004. DOI: 10.1038/sj.jhh.1001953.
  • [40] R A Dickey;J J Janick. Lifestyle modifications in the prevention and treatment of hypertension.. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists(IF=4.6). 2001. PMID:11585378. DOI: 10.4158/EP.7.5.392.
  • [41] Lydia A Bazzano;Torrance Green;Teresa N Harrison;Kristi Reynolds. Dietary approaches to prevent hypertension.. Current hypertension reports(IF=5.1). 2013. PMID:24091874. DOI: 10.1007/s11906-013-0390-z.
  • [42] Francisco J Rios;Augusto C Montezano;Livia L Camargo;Rhian M Touyz. Impact of Environmental Factors on Hypertension and Associated Cardiovascular Disease.. The Canadian journal of cardiology(IF=5.3). 2023. PMID:37422258. DOI: 10.1016/j.cjca.2023.07.002.
  • [43] Tanya M Spruill. Chronic psychosocial stress and hypertension.. Current hypertension reports(IF=5.1). 2010. PMID:20425153. DOI: 10.1007/s11906-009-0084-8.
  • [44] L J Beilin. Stress, coping, lifestyle and hypertension: a paradigm for research, prevention and non-pharmacological management of hypertension.. Clinical and experimental hypertension (New York, N.Y. : 1993)(IF=3.5). 1997. PMID:9247752. DOI: 10.3109/10641969709083183.
  • [45] Sanjay Rajagopalan;Robert D Brook;Thomas Münzel. Environmental Hypertensionology and the Mosaic Theory of Hypertension.. Hypertension (Dallas, Tex. : 1979)(IF=8.2). 2025. PMID:39968647. DOI: 10.1161/HYPERTENSIONAHA.124.18733.
  • [46] Fernando Ribeiro;Manuel Teixeira;Alberto J Alves;Andrew Sherwood;James A Blumenthal. Lifestyle Medicine as a Treatment for Resistant Hypertension.. Current hypertension reports(IF=5.1). 2023. PMID:37470944. DOI: 10.1007/s11906-023-01253-5.
  • [47] Liann Abu Salman;Debbie L Cohen. The Effect of Behavioral Changes on the Treatment of Hypertension.. Current hypertension reports(IF=5.1). 2021. PMID:34820738. DOI: 10.1007/s11906-021-01164-3.
  • [48] G Cohuet;H Struijker-Boudier. Mechanisms of target organ damage caused by hypertension: therapeutic potential.. Pharmacology & therapeutics(IF=12.5). 2006. PMID:16288809. DOI: 10.1016/j.pharmthera.2005.09.002.
  • [49] Bianca A Nguyen;Matthew R Alexander;David G Harrison. Immune mechanisms in the pathophysiology of hypertension.. Nature reviews. Nephrology(IF=39.8). 2024. PMID:38658669. DOI: 10.1038/s41581-024-00838-w.
  • [50] Marialuisa Perrotta;Giuseppe Lembo;Daniela Carnevale. The Interactions of the Immune System and the Brain in Hypertension.. Current hypertension reports(IF=5.1). 2018. PMID:29478153. DOI: 10.1007/s11906-018-0808-8.
  • [51] Serge Yaacoub;Ammar Boudaka;Ali AlKhatib;Gianfranco Pintus;Amirhossein Sahebkar;Firas Kobeissy;Ali H Eid. The pharmaco-epigenetics of hypertension: a focus on microRNA.. Molecular and cellular biochemistry(IF=3.7). 2024. PMID:38424404. DOI: 10.1007/s11010-024-04947-9.
  • [52] J Tamargo;J Duarte;L M Ruilope. New antihypertensive drugs under development.. Current medicinal chemistry(IF=3.5). 2015. PMID:25386825. DOI: 10.2174/0929867321666141106113018.
  • [53] Jun Ma;Yanan Li;Xiangyu Yang;Kai Liu;Xin Zhang;Xianghao Zuo;Runyu Ye;Ziqiong Wang;Rufeng Shi;Qingtao Meng;Xiaoping Chen. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions.. Signal transduction and targeted therapy(IF=52.7). 2023. PMID:37080965. DOI: 10.1038/s41392-023-01430-7.
  • [54] Sándor Bátkai;Thomas Thum. MicroRNAs in hypertension: mechanisms and therapeutic targets.. Current hypertension reports(IF=5.1). 2012. PMID:22052337. DOI: 10.1007/s11906-011-0235-6.
  • [55] Josep Redon;Renata Cifkova;Stephane Laurent;Peter Nilsson;Krzysztof Narkiewicz;Serap Erdine;Giuseppe Mancia; . The metabolic syndrome in hypertension: European society of hypertension position statement.. Journal of hypertension(IF=4.1). 2008. PMID:18806611. DOI: 10.1097/HJH.0b013e328302ca38.
  • [56] Jefry Winner G;Surbhi Jain;Dimpy Gupta. Unveiling novel molecules and therapeutic targets in hypertension - A narrative review.. European journal of pharmacology(IF=4.7). 2024. PMID:39393666. DOI: 10.1016/j.ejphar.2024.177053.
  • [57] Jude S Morton;Christy-Lynn Cooke;Sandra T Davidge. In Utero Origins of Hypertension: Mechanisms and Targets for Therapy.. Physiological reviews(IF=28.7). 2016. PMID:26887677. DOI: 10.1152/physrev.00015.2015.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

hypertension mechanisms · renin-angiotensin-aldosterone system · sympathetic nervous system · endothelial dysfunction · genetic factors

© 2025 MaltSci